Suchergebnisse - "Dorward, Jienchi"

PubPharm (81)

11

Clinical outcomes with second-line dolutegravir in people with virological failure on first-line non-nucleoside reverse transcriptase inhibitor-based regimens in South Africa : a retrospective cohort study

enthalten in: The Lancet. Global health | 2024

von Asare, K. | Sookrajh, Y. | van der Molen, J. | +8

12

Cost-utility analysis of molnupiravir plus usual care versus usual care alone as early treatment for community-based adults with COVID-19 and increased risk of adverse outcomes in the UK PANORAMIC trial

enthalten in: The British journal of general practice : the journal of the Royal College of General Practitioners | 2024

von Png, M. | Harris, V. | Grabey, J. | +29

13

Clinical Outcomes After Viremia Among People Receiving Dolutegravir vs Efavirenz-Based First-line Antiretroviral Therapy in South Africa

enthalten in: Open forum infectious diseases | 2023

von Asare, K. | Lewis, L. | van der Molen, J. | +8

14

Clinical outcomes after extended 12-month antiretroviral therapy prescriptions in a community-based differentiated HIV service delivery programme in South Africa : a retrospective cohort study

enthalten in: Journal of the International AIDS Society | 2023

von Lewis, L. | Sookrajh, Y. | van der Molen, J. | +8

15

Diagnostic accuracy of a point-of-care urine tenofovir assay, and associations with HIV viraemia and drug resistance among people receiving dolutegravir and efavirenz-based antiretroviral therapy

enthalten in: Journal of the International AIDS Society | 2023

von Dorward, J. | Lessells, R. | Govender, K. | +9

16

Point-of-Care Viral Load Testing to Manage HIV Viremia During the Rollout of Dolutegravir-Based ART in South Africa : A Randomized Feasibility Study (POwER)

enthalten in: Journal of acquired immune deficiency syndromes (1999) | 2023

von Dorward, J. | Sookrajh, Y. | Lessells, R. | +13

17

Platform adaptive trial of novel antivirals for early treatment of COVID-19 In the community (PANORAMIC) : protocol for a randomised, controlled, open-label, adaptive platform trial of community novel antiviral treatment of COVID-19 in people at increased risk of more severe disease

enthalten in: BMJ open | 2023

von Gbinigie, O. | Ogburn, E. | Allen, J. | +45

18

Clinical outcomes after the introduction of dolutegravir for second-line antiretroviral therapy in South Africa: a retrospective cohort study

enthalten in: bioRxiv.org | 2023

von Asare, K. | Sookrajh, Y. | van der Molen, J. | +8

19

Clinical outcomes after the introduction of dolutegravir for second-line antiretroviral therapy in South Africa : a retrospective cohort study

enthalten in: medRxiv : the preprint server for health sciences | 2023

von Asare, K. | Sookrajh, Y. | van der Molen, J. | +8

20

Viraemia and HIV drug resistance among people receiving dolutegravir versus efavirenz-based first-line antiretroviral therapy

enthalten in: bioRxiv.org | 2023

von Dorward, J. | Sookrajh, Y. | Lessells, R. | +9